Insulin Resistance Specialists on Long Island
Insulin resistance is one of the most common metabolic conditions in the country — and one of the most underdiagnosed. It doesn’t cause dramatic symptoms early on. Instead, it shows up as weight that accumulates despite effort, energy that dips after meals, cravings that feel disproportionate to what you ate, and a general sense that your metabolism isn’t cooperating the way it once did. Left unaddressed, it sits at the root of type 2 diabetes, cardiovascular disease, and accelerated hormonal decline.
The reason it gets missed is that standard screening often checks fasting glucose and HbA1c — which don’t become abnormal until insulin resistance has been building for years. Fasting insulin and the HOMA-IR calculation tell a more complete story, much earlier. Many people who are told their blood sugar is fine have meaningfully elevated insulin driving fat storage and energy dysregulation in the background.
Patients across Nassau County, Long Island, and all of New York can access a complete metabolic evaluation via telehealth through StackMD. A consultation and a comprehensive lab panel establishes the full picture — and treatment follows from there.
Getting started takes under 10 minutes — no in-person visit required.
Condition Focus
Insulin Resistance
Fasting insulin and HOMA-IR evaluated early — when the problem is most addressable — not after blood sugar has already crossed a threshold.
70%
of adults with insulin resistance go undiagnosed on standard screening
6–12
Weeks to measurable metabolic improvement with GLP-1 therapy
The process
How It Works
Simple steps, clear labs, and a plan built around your actual metabolism — not a template.
Schedule a telehealth consultation — no office visit, no waiting room. We meet you where you are.
Complete a comprehensive metabolic panel including fasting insulin, HOMA-IR, HbA1c, lipids, and hormones at a draw site near you.
Receive a personalized treatment plan — GLP-1 therapy, hormone optimization, dietary guidance, or a combination — matched to where you actually are on the metabolic spectrum.
Signs You May Have Insulin Resistance
These signs often show up together when insulin resistance is part of the picture.
- Energy crashes after meals, especially carbohydrate-heavy ones
- Persistent cravings for sugar and refined carbs
- Weight concentrated around the midsection that doesn't respond to dieting
- Feeling hungry again shortly after eating a full meal
- Difficulty losing weight even with consistent caloric restriction
- Brain fog or cognitive slowness, especially in the afternoon
- Fatigue that varies with meals — better early, worse after eating
- Elevated triglycerides or low HDL on routine blood work
- Dark skin patches on the neck or under the arms (acanthosis nigricans)
Why patients look deeper
Insulin resistance is deeply connected to weight gain, hormone imbalance, thyroid dysfunction, and fatigue — each of which can drive and compound the others. StackMD evaluates and treats these conditions together, not in silos.
Root causes
What Causes Insulin Resistance?
The right treatment starts with understanding what’s actually driving the metabolic dysfunction.
High-Sugar, High-Refined-Carbohydrate Diet
Chronically elevated carbohydrate intake drives repeated insulin surges. Over time, cells downregulate their insulin receptors in response to constant signaling — a protective mechanism that becomes the problem. Diets high in refined carbohydrates and added sugars are the most common modifiable driver of insulin resistance.
Excess Visceral Fat
Adipose tissue in the abdominal cavity is metabolically active and inflammatory. It releases cytokines and free fatty acids that interfere with insulin signaling in the liver, muscle, and pancreas. The abdominal weight many patients notice as their primary complaint is often both a symptom and a driver of insulin resistance simultaneously.
Sedentary Lifestyle
Muscle is the body's primary glucose sink — the tissue most responsible for clearing blood sugar after meals. Physical inactivity reduces muscle glucose uptake and insulin sensitivity. Even modest increases in physical activity can produce meaningful improvements in insulin response.
Chronic Stress and Elevated Cortisol
Cortisol raises blood glucose to prepare for fight-or-flight responses. When cortisol is chronically elevated from stress, poor sleep, or metabolic dysfunction, glucose remains persistently elevated — requiring more insulin to manage and accelerating insulin resistance over time.
Poor Sleep Quality and Sleep Apnea
Even a few nights of poor sleep measurably impairs insulin sensitivity. Sleep apnea, which produces intermittent oxygen drops and repeated cortisol surges throughout the night, is strongly associated with insulin resistance. Treating sleep apnea often produces meaningful metabolic improvement.
Chronic Inflammation
Low-grade inflammation, regardless of source, interferes with insulin receptor function. Inflammatory cytokines block insulin signaling pathways. Gut dysfunction, autoimmune activity, and metabolic disease are all sources of chronic inflammation that contribute to insulin resistance.
Thyroid Dysfunction
Thyroid hormones regulate glucose metabolism and insulin sensitivity. Hypothyroidism slows glucose uptake by peripheral tissues and alters the pancreatic insulin response. Suboptimal thyroid function can drive or worsen insulin resistance and is commonly co-present.
Hormonal Imbalance
Low testosterone in men directly impairs insulin sensitivity and promotes visceral fat accumulation. PCOS in women, characterized by elevated androgens, is closely linked to insulin resistance. Estrogen deficiency in menopause also worsens insulin dynamics. Hormonal correction is often a necessary part of treating insulin resistance effectively.
Genetic Predisposition and Family History
Insulin resistance has a meaningful genetic component. People with a family history of type 2 diabetes, PCOS, or metabolic syndrome carry higher baseline risk. Genetic predisposition doesn't make insulin resistance inevitable — but it does mean earlier evaluation and more proactive intervention make practical sense.
How StackMD Treats Insulin Resistance
The StackMD approach
Insulin resistance can drive hunger, weight gain, inflammation, and long-term metabolic risk before diabetes is ever diagnosed — and that’s exactly when it’s most treatable.
Most metabolic screenings catch insulin resistance after blood sugar is already visibly elevated — which means it’s been building for years. StackMD measures fasting insulin and HOMA-IR early, when the problem is most addressable. A complete metabolic evaluation includes fasting insulin, fasting glucose, HOMA-IR, HbA1c, lipid panel, inflammatory markers, and a comprehensive hormone workup. This panel identifies where insulin resistance sits on the spectrum and what’s driving it. The consultation and lab order are handled via telehealth through StackMD — no office visit required. Lab testing is completed at a local draw site near you.
For patients with meaningful insulin resistance, GLP-1 therapy — compounded tirzepatide or semaglutide — is among the most effective metabolic interventions available. Compounded formulations are used when clinically appropriate for individualized dosing not available with commercially manufactured products, allowing the protocol to be precisely adjusted based on your individual response and tolerability. Tirzepatide’s dual GIP/GLP-1 mechanism has shown particularly strong results in insulin sensitivity improvement, and metabolic improvement often precedes significant weight reduction.
Hormone optimization is integrated into the plan where relevant — low testosterone in men and hormone imbalance in women both impair insulin sensitivity and are addressed as part of the same evaluation. IV therapy through Stack Mobile IV can provide targeted metabolic support. Dietary guidance focused on blood sugar regulation — not generic caloric restriction — is part of the clinical conversation from the first visit.
Your blood sugar looks fine. Your insulin might not.
Get a real picture of your metabolic health — not just whether you’re technically pre-diabetic. Fasting insulin and HOMA-IR tell a more complete story, and the earlier you have it, the more options you have.
Serving Nassau County, Long Island, and all of New York. No in-person visit required to start.
Common questions
Frequently Asked Questions
Answers to the questions patients usually ask before they get started.
What is insulin resistance?
Insulin resistance occurs when the body’s cells stop responding efficiently to insulin. To compensate, the pancreas produces more insulin. Over time, this leads to chronically elevated insulin, fat storage (especially visceral), and eventually elevated blood sugar if left unaddressed.
Is insulin resistance the same as diabetes?
No, but it sits on the same spectrum. Insulin resistance is a pre-diabetic state that can progress to type 2 diabetes if not addressed. It can also exist for years producing significant metabolic symptoms — weight gain, fatigue, brain fog, cravings — before blood sugar becomes abnormal enough to meet a diabetes diagnosis.
Can insulin resistance be reversed?
Yes, in many cases — particularly when addressed before it progresses to overt diabetes. GLP-1 therapy, dietary modification, physical activity, hormone optimization, and weight reduction can meaningfully restore insulin sensitivity. The earlier it’s identified, the more reversible it tends to be.
Can GLP-1 medications help insulin resistance even without significant weight loss?
Yes. GLP-1 receptor agonists — and particularly tirzepatide, which also activates GIP receptors — improve insulin sensitivity through mechanisms independent of weight loss, including direct effects on glucose regulation and pancreatic function.
Does testosterone affect insulin sensitivity?
Yes. Low testosterone in men is directly associated with impaired insulin sensitivity and increased visceral fat. Restoring testosterone to optimal levels — through TRT or enclomiphene — often produces measurable metabolic improvement. Hormonal and metabolic treatment at StackMD are planned together, not in isolation.
What diet is best for insulin resistance?
Diets that minimize blood sugar spikes — lower in refined carbohydrates and added sugars, higher in protein and fiber — are consistently effective for improving insulin sensitivity. StackMD incorporates individualized dietary guidance into the metabolic treatment plan.
What blood tests are used to evaluate insulin resistance?
A complete evaluation includes fasting insulin, fasting glucose, HOMA-IR, HbA1c, and a lipid panel. These are more informative than glucose alone, particularly in early-stage insulin resistance where blood sugar may still appear normal on standard screening.
Related conditions
Insulin resistance is deeply connected to weight gain, hormone imbalance, thyroid dysfunction, and fatigue — each of which can drive and compound the others. StackMD evaluates and treats these conditions together.
Weight Gain
Look at insulin, appetite, thyroid, and hormones — not calories alone.
Hormone Imbalance
Treat the pattern, not a single lab value in isolation.
Fatigue & Low Energy
Search for hormone, thyroid, nutrient, and sleep-related drivers.
Start Your Metabolic Evaluation Today
Get a real picture of your metabolic health — not just whether you’re technically pre-diabetic. A telehealth consultation and a comprehensive lab panel is all it takes. Serving Nassau County, Long Island, and all of New York.
Telehealth-first · In-person available when needed
Areas Served
StackMD serves patients across New York State via telemedicine — including Nassau County, Suffolk County, and the greater New York metro area. For in-person procedures, we see patients at our Albertson, NY location, serving Garden City, Mineola, Great Neck, Manhasset, Roslyn, Westbury, New Hyde Park, Jericho, Syosset, Port Washington, Massapequa, Hicksville, Levittown, and surrounding Long Island communities.
Medical Disclaimer
This page is for informational purposes only and does not constitute medical advice. Please consult a qualified physician before making any treatment decisions.